<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Claus</forename><surname>Lüers</surname></persName>
							<email>clausluers@mac.com</email>
							<affiliation key="aff0">
								<orgName type="institution" key="instit1">University of Oldenburg</orgName>
								<orgName type="institution" key="instit2">European Medical School Oldenburg-Groningen</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Frank Edelmann</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<orgName type="institution">University of Göttingen</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University</orgName>
								<address>
									<addrLine>Campus Virchow</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Rolf</forename><surname>Wachter</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Cardiology and Pneumology</orgName>
								<orgName type="institution">University of Göttingen</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Burkert Pieske</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University</orgName>
								<address>
									<addrLine>Campus Virchow</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><forename type="middle">Meinhard</forename><surname>Mende</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Clinical Trial Center</orgName>
								<orgName type="institution">University of Leipzig</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Christiane</forename><surname>Angermann</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Comprehensive Heart Failure Center</orgName>
								<orgName type="department" key="dep2">and Department of Internal Medicine Cardiology</orgName>
								<orgName type="institution" key="instit1">University of Würzburg</orgName>
								<orgName type="institution" key="instit2">University Hospital Würzburg</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Georg</forename><surname>Ertl</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Comprehensive Heart Failure Center</orgName>
								<orgName type="department" key="dep2">and Department of Internal Medicine Cardiology</orgName>
								<orgName type="institution" key="instit1">University of Würzburg</orgName>
								<orgName type="institution" key="instit2">University Hospital Würzburg</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Hans-Dirk</forename><surname>Düngen</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Department of Cardiology</orgName>
								<orgName type="institution">Charité University</orgName>
								<address>
									<addrLine>Campus Virchow</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Stefan</forename><surname>Störk</surname></persName>
							<affiliation key="aff4">
								<orgName type="department" key="dep1">Comprehensive Heart Failure Center</orgName>
								<orgName type="department" key="dep2">and Department of Internal Medicine Cardiology</orgName>
								<orgName type="institution" key="instit1">University of Würzburg</orgName>
								<orgName type="institution" key="instit2">University Hospital Würzburg</orgName>
								<address>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="institution" key="instit1">Carl von Ossietzky University Oldenburg</orgName>
								<orgName type="institution" key="instit2">European Medical School Oldenburg-Groningen</orgName>
								<address>
									<addrLine>Carl-von-Ossietzky Strasse 9-11</addrLine>
									<postCode>26129</postCode>
									<settlement>Oldenburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Prognostic impact of diastolic dysfunction in systolic heart failure-A cross-project analysis from the German Competence Network Heart Failure</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">EE9A2B2B56C40BD0C1D1B8031F4C28B8</idno>
					<idno type="DOI">10.1002/clc.22710</idno>
					<note type="submission">Received: 4 December 2016 Revised: 27 February 2017 Accepted: 28 February 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:19+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Diastolic Function</term>
					<term>Systolic Function</term>
					<term>Echocardiography</term>
					<term>Epidemiology</term>
					<term>Heart Failure With Preserved Ejection Fraction</term>
					<term>Heart Failure With Reduced Ejection Fraction</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: We investigated the modifying role and prognostic importance of diastolic dysfunction (DD) in patients with heart failure and systolic dysfunction (SD).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Hypothesis:</head><p><s>The echocardiographic evaluation of diastolic function in patients with SD provides further prognostic information.</s></p><p><s>Methods: From the German Competence Network Heart Failure, 1046 heart failure patients with reduced left ventricular ejection fraction (LVEF; &lt;50%) were echocardiographically studied and followed for a median of 5 years.</s><s>SD was subdivided into nonsevere (LVEF 36%-49%) and severe (LVEF ≤35%); DD was subdivided into nonsevere (E/E 0 &lt;15) and severe (E/E 0 ≥15).</s></p><p><s>Results: In general, severe SD was associated with higher hazard ratios (HRs; 2-fold to 3.5-fold) for all endpoints (all-cause death, cardiac death, cardiovascular hospitalization, duration of hospitalization).</s><s>Patients with severe SD had a 2.5-fold risk of death (95% confidence interval [CI]:</s></p><p><s>1.84-3.47,</s><s>P &lt; 0.001), and patients with severe DD showed a 1.8-fold risk (95% CI: 1.17-2.61,</s><s>P = 0.004).</s><s>Furthermore, we observed a strong interaction of SD and DD: concomitant severe DD in patients with moderate SD increased risk substantially (HR: 1.73, 95% CI: 1.16-2.6,</s><s>P = 0.007); by contrast, in patients with severe SD, additional presence of severe DD added little or no risk (HR for interaction: 0.5-1.2).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions:</head><p><s>In heart failure patients with reduced LVEF, the evaluation of diastolic function provides additional prognostic information.</s><s>Although severe SD generally increased the risk for all endpoints, the degree of DD and its impact as a prognostic marker for overall and cardiovascular mortality appeared of particular relevance in subjects with nonsevere SD.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>HFrEF. <ref type="bibr" target="#b7">8</ref> The landmark report of Owan et al found that prognosis in patients with HFpEF is only slightly less grave than in patients with with HFrEF. <ref type="bibr" target="#b8">9</ref></s><s>However, there is an ongoing discussion whether DD in HFrEF should be regarded as a pathophysiological factor on its own right, which autonomously contributes to disease progression, or rather as a precursor or sequel occurring in the context of SD.</s><s>An HFpEF paradigm introduced by Paulus and Tschöpe in 2013 proposes to include comorbidities, plasma markers of inflammation, and vascular response into diagnostic algorithms.</s><s>Of importance, this aims at restoring myocardial protein kinase C activity.</s><s>Substantially, myocardial remodeling in HFpEF differs from HFrEF, in which remodeling is driven by loss of cardiomyocytes. <ref type="bibr" target="#b9">10,</ref><ref type="bibr" target="#b10">11</ref></s><s>Echocardiographic algorithms that should be employed to diagnose DD in healthy and diseased persons are still under debate, as are their diagnostic and therapeutic implications.</s><s>Currently, in subjects with normal left ventricular ejection fraction (LVEF), the ratio of early transmitral spectral Doppler velocity to early tissue Doppler mitral annular velocity (E/e 0 ratio) is recommended as the initial step for estimation of LV filling pressures; whereas in patients with reduced LVEF, mitral inflow velocities may be used first. <ref type="bibr" target="#b11">12</ref></s><s>e current study aimed to investigate the prognostic utility of the mutual contribution of SD and DD to prognosis in patients with HFrEF.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">| METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">| Patients</head><p><s>This retrospective cohort study investigated patients included in follow-up studies performed within the German Competence Network Heart Failure (CNHF), as previously described.</s><s>The CNHF is a government-sponsored nationwide network consisting of infrastructure and scientific projects dedicated to improvement in efficiency and efficacy of research in HF, quality of care for HF patients, and public education. <ref type="bibr" target="#b12">13</ref></s><s>The Central Biomaterial Bank is a project of the CNHF that provides a central facility to collect all biomaterial from each patient enrolled in one of the network's clinical trials for the purposes of several ongoing and future scientific projects. <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b14">15</ref></s><s>By using the CNHF database (n = ~12 000), we identified all patients with clinical signs of HF and documented SD (LVEF &lt;50%; n = 1046) measured by echocardiography at the respective time of study inclusion (see Supporting Information, Table <ref type="table">3</ref>, in the online version of this article).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.2">| Study design, setting, and examinations</head><p><s>All diagnostic procedures within the CNHF, including echocardiography, were performed by trained personnel according to standard operating procedures based on international guidelines.</s><s>The CNHF mandates the acquisition of a dedicated harmonized clinical dataset for its clinical projects.</s><s>All information including medical history, physical examination, electrocardiography, echocardiography, and patient questionnaires was collected using predefined standard operating procedures. <ref type="bibr" target="#b15">16,</ref><ref type="bibr" target="#b16">17</ref></s><s>We defined chronic kidney disease by glomerular filtration rate of ≤30 mL/min.</s><s>Serial echocardiography was performed using a prespecified protocol by experienced sonographers in accordance with the recommendations of the American Society of Echocardiography.</s><s>LVEF was determined from the apical 2-and 4chamber view using the Simpson biplane method; or, if that was not feasible, the Simpson monoplane method was used.</s><s>The left ventricular (LV) end-diastolic diameter was measured from the left parasternal long-axis view at the level of the mitral chordae with the ultrasound beam directed perpendicularly to the LV endocardial surfaces.</s><s>An LVEF ≤35% was accepted as an indicator for severe SD, whereas the remaining subjects were considered nonsevere SD (ie, LVEF 36%-49%).</s><s>Similarly, and in accordance with the European consensus statement on the diagnosis of HF with normal LVEF by the Heart Failure and Echocardiography associations of the European Society of Cardiology and recommendations of the American Society of Echocardiography, we studied diastolic function in subgroups of severe DD (E/e 0 ≥15) and nonsevere DD (E/e 0 &lt;15).</s><s>The average (septal and lateral) e 0 velocity was used. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref></s><s>In case of atrial fibrillation, 10 cycles of best-representative E/e 0 were analyzed and averaged. <ref type="bibr" target="#b17">18</ref></s><s>Using these criteria, each patient was categorized into 1 of the following 4 subgroups: nonsevere SD with concomitant nonsevere DD, nonsevere SD with severe DD, severe SD with nonsevere DD, and severe SD with severe DD.</s></p><p><s>All studies within the CNHF comply with the Declaration of Helsinki.</s><s>All protocols were approved by the responsible ethics committees, and all patients gave written informed consent prior to study start.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">| Statistical analysis</head><p><s>Continuous variables are expressed as mean (standard deviation) and categorical variables described by numbers and percentages.</s><s>Means of continuous variables were compared by t test for independent samples.</s><s>Categorical variables were tested by the χ 2 test or Fisher exact test, as appropriate.</s><s>Duration of HF was classified as ≤ and &gt;5 years.</s><s>Hospital length of stay was considered the cumulative number of days spent in hospital over the observation period and was compared by Mann-Whitney U test.</s><s>Time-to-event data were depicted by Kaplan-Meier curves and compared by log-rank test.</s></p><p><s>Age-and sex-adjusted hazard ratios (HRs) with corresponding 95% confidence intervals (CIs) were calculated by Cox proportional hazard regression analysis.</s><s>Looking for variables possibly associated with the endpoints of death, cardiac death, and a composite of all-cause and cardiovascular (CV) hospitalization and death, respectively, we built multiple Cox regression models.</s><s>From a total of 20 risk factors and comorbidities, a subset was selected by the LASSO method (least absolute selection and shrinkage operator), <ref type="bibr" target="#b18">19</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">| Patient characteristics</head><p><s>Included into this analysis were 1046 patients from the database of the CNHF with an LVEF of &lt;50% participating in 3 different clinical followup studies (see Supporting Information, Table <ref type="table">3</ref>, in the online version of this article).</s><s>The mean age of the study participants was 70 years, 26% were female, and 85% suffered from HF of New York Heart Association functional class II or III.</s><s>Out of these patients, 546 (52%) demonstrated nonsevere SD and 500 (48%) severe SD.</s><s>Regarding DD, 693 (66%) patients demonstrated nonsevere DD and 353 (34%) patients showed severe DD (see Supporting Information, Table <ref type="table">4</ref>, in the online version of this article).</s><s>For baseline characteristics of study patients stratified by their echocardiographically determined systolic and diastolic functional status (see Supporting Information, Table <ref type="table">5</ref>, in the online version of this article).</s><s>Patients with nonsevere SD presented a mean LVEF of 42%, as compared with a mean LVEF of 28% in patients with severe SD (P &lt; 0.001).</s><s>No differences in LVEF were evident between the patient groups with nonsevere and severe DD.</s><s>Moreover, 37% of patients with nonsevere DD demonstrated an E/e 0 ≤8.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">| Complementary prognostic information of SD and DD</head><p><s>In the overall population, severe DD (vs nonsevere DD) was significantly associated with the combined endpoint of cardiac death and CV hospitalization even after adjustment for age and sex (HR: 2.01, 95% CI: 1.52-2.66,</s><s>P &lt; 0.001).</s><s>Severe SD was associated with higher hazards for all endpoints.</s><s>Furthermore, we observed a strong interaction subgroup effect for SD and DD: In patients with nonsevere SD, additional severe DD resulted in a markedly higher risk (HR: 1.73, 95% CI 1.16-2.60,</s><s>P = 0.007 for all-cause mortality; HR: 1.82, 95% CI: 0.97-3.42,</s><s>P = 0.061 for cardiac mortality; and HR: 1.42, 95% CI: 0.98-2.08,</s><s>P = 0.067 for cardiac death and CV hospitalization).</s><s>By contrast, in patients with severe SD, additional presence of severe DD added little or no risk.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">| All-cause mortality</head><p><s>Patients with severe SD had a 2.5-fold risk of death compared with patients with nonsevere SD (HR: 2.53, 95% CI: 1.84-3.47,</s><s>P &lt; 0.001).</s></p><p><s>Likewise, severe DD was associated with a higher mortality risk (HR:</s></p><p><s>1.75, 95% CI: 1.17-2.61,</s><s>P = 0.004), but the risk increase was smaller than in patients with severe SD.</s><s>Size and direction of the interaction term SD*DD (HR: 0.63, 95% CI: 0.38-1.05,</s><s>P = 0.073) indicated that the mortality risk for patients with severe SD plus severe DD was not as high as might have been expected from a fully additive risk increase of both single risks combined.</s><s>Considerable risk was attributable to age alone.</s><s>As such, the risk increase (HR: 1.78) conferred by an increment in age by 10 years of similar magnitude as the risk conferred by concomitant severe DD.</s><s>Females demonstrated lower mortality than males, but this effect was not significant (Figure <ref type="figure" target="#fig_1">1</ref>, Table <ref type="table" target="#tab_0">1</ref>).</s></p><p><s>Especially with respect to all-cause mortality, we observed a strong interaction effect for SD and DD in that in patients with only moderate SD, severe DD increased risk substantially (HR: 1.73, 95% CI: 1.16-2.6,</s><s>P = 0.007).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">| Cardiac mortality</head><p><s>Risk of cardiac death for severe SD and severe DD patients was even higher than risk of overall death (severe SD: HR: 3.51, 95% CI: 2.19-5.64,</s><s>P &lt; 0.001; severe DD: HR: 1.85, 95% CI: 0.99-3.47,</s><s>P = 0.055) and the interaction effect was even slightly more pronounced (HR: 0.53, 95% CI: 0.25-1.13,</s><s>P = 0.070).</s><s>Age was also a significant predictor of cardiac death (HR: 1.63 per decade, 95% CI: 1.30-2.04,</s><s>P &lt; 0.001); however, a risk difference between females and males could not be shown.</s><s>Additionally, unadjusted analysis gave similar results with respect to SD and DD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.5">| Cardiac death and CV hospitalization</head><p><s>Severe SD, as opposed to nonsevere SD, was associated with a nearly doubled risk for cardiac death or CV hospitalization, whereas no impact of severe DD could be shown in these patients with at least moderate SD.</s><s>Neither age nor sex had predictive utility in these analyses (age: HR: 0.93, 95% CI: 0.81-1.06,</s><s>P = 0.263; female sex: HR: 1.22, 95% CI: 0.92-1.62,</s><s>P = 0.170; Figure <ref type="figure" target="#fig_2">2</ref>, Table <ref type="table" target="#tab_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.6">| Duration of hospitalization</head><p><s>The length of hospital stay for both all-cause and CV hospitalizations strongly depended on the severity of SD, whereas severity of DD was irrelevant in patients with both nonsevere or severe SD (Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.7">| Covariates associated with clinical endpoints</head><p><s>We built multiple models for 2 purposes: (1) to adjust for possible confounders (e.g., age and sex), and (2) to search for CV risk factors and comorbidities associated with clinical endpoints.</s><s>As expected, the impact of severe SD was not substantially weakened by adjustment by confounding factors.</s><s>The effect of DD vanished after inclusion of other risk factors.</s><s>Nevertheless, a sizeable interaction effect remained.</s><s>Syncope in medical history, malignancy, and hyperuricemia were the variables with the strongest predictive potential (all HR &gt;2; all P &lt; 0.001).</s><s>Severe SD, ex-smoker, anemia, female sex, and low body mass index were further identified as significant factors.</s><s>In these multiple models, risks of age, hyperlipidemia, duration of HF, and the interaction term SD*DD were rather weak and nonsignificant factors (Table <ref type="table" target="#tab_0">1</ref> and Figure <ref type="figure" target="#fig_3">3</ref>).</s><s>Adjusting for atrial fibrillation did not alter the results of multiple models.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">| DISCUSSION</head><p><s>The present study investigated in a large cohort of patients with SD the incremental impact of DD on hard clinical endpoints.</s><s>Our analyses demonstrated that the degree of SD was the dominant prognostic driver in these patients, but DD had a major modifying effect, rendering it an important research issue and potential therapeutic target.</s><s>Our findings are consistent with but extend previous reports such as the Heart Failure and a Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) trial and a few smaller studies. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref></s><s>Because patients with SD were investigated, we focus in the discussion below on the differential prognostic utility of DD in SD.</s></p><p><s>We observed that DD had a more pronounced impact on prognosis in patients with nonsevere SD compared with severe SD.</s><s>This may appear intuitive, because it is more difficult to demonstrate a risk increase in patients already at high risk.</s><s>Further, in severe SD, pathophysiological processes may well overlap with those responsible for DD, although is still unclear whether a severely compromised LVEF always represents the common final pathway of aggravated SD and DD. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref></s><s>tients exhibiting nonsevere SD in combination with severe DD represent an interesting subgroup that may contain patients with "cryptic HFpEF".</s><s>It is known that increased ventricular stiffness is associated with systolic abnormalities (ie, it could be demonstrated that cardiac output and contractile response are often blunted during exercise in HFpEF patients despite a preserved or only mildly reduced systolic function at rest).</s><s>Such blunted contractile response has been shown to strongly associate with an impaired exercise tolerance. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b24">25</ref></s><s>Mechanical cardiac dyssynchrony may contribute to the progression of SD because systolic longitudinal strain is conceived particularly low in patients with HFpEF at rest and fails to increase during exercise. <ref type="bibr" target="#b25">26</ref></s><s>Such failing response in longitudinal strain increase in patients with HFpEF may very well be a precursor of a reduced systolic function. <ref type="bibr" target="#b26">27</ref></s><s>Beyond these mechanisms, a deterioration of systolic longitudinal strain may also be involved in DD. <ref type="bibr" target="#b27">28</ref> This might explain the fact that additional severe DD indicated a relevant risk increase in our patient group with nonsevere SD.</s><s>Motoki and colleagues showed that in patients with chronic systolic HF and a mean LVEF of 26%, worsening of LV global longitudinal strain was associated with a more pronounced LV DD and both right ventricular (RV) SD and DD, and provided incremental prognostic value over and above LVEF. <ref type="bibr" target="#b28">29</ref></s><s>e method of choice to reliably assess diastolic function in patients with compromised LVEF is still under debate.</s><s>The E/e 0 ratio seems to perform reasonably well in subjects at risk for or with mild cardiac disease but may have limited value in subjects with severe SD, most likely due to concomitant hemodynamic and structural changes that may decrease the validity of tissue Doppler measurements. <ref type="bibr" target="#b29">30,</ref><ref type="bibr" target="#b30">31</ref></s><s>By contrast, in a recent study by Cabrera-Schulmeyer et al, the E/e 0 ratio proved useful in the prediction of morbid events  Data are presented as median (IQR).</s></p><formula xml:id="formula_0">(A) (B)</formula><p><s>Hospital LOS is modified by the degree of DD and SD in all patients (allcause hospitalization) and patients hospitalized for CV reasons (CV hospitalization).</s><s>after noncardiac surgery (ie, less sick patients).</s><s>In this study, the mean LVEF was 41% to 47%, and the lowest LVEF was associated with highest E/e 0 . 32</s><s>However, in this study no differentiation between nonsevere and severe SD was made.</s><s>In a study by Kuijk et al in patients with peripheral arterial disease, the presence of isolated diastolic, systolic, or combined LV dysfunction was independently associated with increased CV mortality risk irrespective of the presence of diabetes mellitus, and patients with combined SD and DD had the worst CV prognosis. <ref type="bibr" target="#b32">33</ref></s><s>Lee et al showed that a decrease of an initially high e 0 /a 0 ratio predicted a more favorable outcome with respect to long-term therapy in clinically stable patients with chronic HF and severe SD. <ref type="bibr" target="#b33">34</ref> Tang et al demonstrated that in patients with chronic systolic HF and pronounced cardiac remodeling, septal tissue Doppler measurements were more reliable and clinically relevant than lateral measurements in the assessment of DD. <ref type="bibr" target="#b34">35</ref> In our study, we calculated both ratios, septal and lateral E/e 0 , but neither parameter excelled.</s><s>In conclusion, in these studies it could be demonstrated that both parameters provide a very powerful tool for risk stratification. <ref type="bibr" target="#b35">36,</ref><ref type="bibr" target="#b36">37</ref></s><s>It remains to be shown, however, that such complex determination of diastolic function will be used by clinicians in a real-world setting such as ambulatory care. <ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b34">35</ref></s><s>rthermore, considering the recent European Society of Cardiology guidelines introducing the concept of HFmrEF (HF with midrange ejection fraction), our investigations become more important, because our data demonstrate a special effect of diastolic dysfunction on myocardial performance in patients with nonsevere SD. <ref type="bibr" target="#b37">38</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4.1">| Study limitations</head><p><s>The current project addresses a post-hoc research question to a set of prospective datasets collected in a harmonized fashion.</s><s>By definition, such a retrospective observational approach cannot determine causation, only association.</s><s>However, endpoint phenotypes were collected in a standardized manner across all CNHF projects, thus ensuring comparability of outcomes.</s></p><p><s>This study was not designed to investigate the validity of the echocardiographic diastolic measurements under circumstances of SD.</s><s>As such, no comparison with the reference standard was available (ie, invasive hemodynamic assessment).</s><s>Enrollment of patients from various studies within the German CNHF resulted in a heterogeneous patient sample regarding predominant cause of HF and number and severity of comorbidities.</s><s>However, because data were acquired with a high degree of cross-study harmonization, we consider our results plausible and generalizable.</s></p><p><s>In our study we used E/e 0 as a key parameter to establish a threshold between none, none-severe, and severe DD.</s><s>The CNHF was initiated in 2003. <ref type="bibr" target="#b12">13</ref></s><s>Since then, the concept of DD and diastolic HF has repeatedly been modified, and no final consensus has been reached.</s><s>All studies of the present analysis targeted HF; however, DD was not an inclusion criterion in all studies.</s><s>Nonetheless, in all studies, E/A pattern and tissue Doppler were measured in a harmonized fashion.</s><s>These parameters are still considered key for the diagnosis of DD and diastolic HF.</s><s>With respect to the work by Paulus et al and keeping in mind that E/e 0 approximately mirrors LV wall tension, we decided to use an E/e 0 ≥15 cutoff to establish a threshold between none, nonsevere, and severe DD. <ref type="bibr" target="#b10">11</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">| CONCLUSION</head><p><s>The current study demonstrates that the degree of SD dominates prognosis in patients with HFrEF.</s><s>However, the echocardiographic evaluation of diastolic function in these patients provides further prognostic information, in particular in subjects with nonsevere SD.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>without giving particular consideration to P values.</s><s>Variables with nonzero coefficients were included into a final Cox regression model to estimate HR with 95% CI.</s><s>Multiple hospitalization was analyzed by means of an Anderson-Gill counting process model 20 including an interaction term SD*DD.</s><s>Statistical analysis was performed using SPSS software version 22 (IBM Corp., Armonk, NY).</s><s>In addition, LASSO and Anderson-Gill procedure and respective forest plot were generated by means of the R packages coxph, penalized and Hmisc (R Foundation for Statistical Computing, http://www.r-project.org).</s><s>All tests were 2-sided at a significance level of 5%.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>FIGURE 1</head><label>1</label><figDesc><div><p><s>FIGURE 1 All-cause mortality in patients with HFrEF (Kaplan-Meier plot).</s><s>(A) Patients with ns-SD.</s><s>(B) Patients with s-SD.</s><s>Graphs are stratified by level of DD: E/e 0 &lt;15 (ns-DD) and E/e 0 ≥15 (s-DD).</s><s>HRs with 95% CIs are computed from age-and sex-adjusted Cox regression (ns-SD/ns-DD, n = 396; ns-SD/s-DD, n = 150; s-SD/ns-DD, n = 297; s-SD/s-DD, n = 203).</s><s>Abbreviations: CI, confidence interval; DD, diastolic dysfunction; HFrEF, heart failure with reduced ejection fraction; HR, hazard ratio; ns, nonsevere; s, severe; SD, systolic dysfunction.</s></p></div></figDesc><graphic coords="3,57.13,480.92,481.00,224.50" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIGURE 2</head><label>2</label><figDesc><div><p><s>FIGURE 2 Occurrence of CV endpoints in patients with HFrEF (Kaplan-Meier plot).</s><s>(A) All-cause death or hospitalization.</s><s>(B) CV death or hospitalization.</s><s>Graphs are stratified by combinations of type of HF (DD vs SD) and severity (ns vs s).</s><s>HRs with 95% CIs are shown for selected group comparisons and were computed from age-and sex-adjusted Cox regression.</s><s>Abbreviations: CI, confidence interval; CV, cardiovascular; DD, diastolic dysfunction; HF, heart failure; HFrEF, heart failure and reduced ejection fraction; HR, hazard ratio; ns, nonsevere; s, severe; SD, systolic dysfunction.</s></p></div></figDesc><graphic coords="5,57.58,50.15,480.27,273.16" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIGURE 3</head><label>3</label><figDesc><div><p><s>FIGURE 3 Risk factors and comorbidities associated with cardiac death or cardiovascular hospitalization.</s><s>Abbreviations: BMI, body mass index; CI, confidence interval; DD, diastolic dysfunction; SD, systolic dysfunction.</s></p></div></figDesc><graphic coords="5,313.33,560.27,228.28,144.64" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head></head><label></label><figDesc><div><p><s>Meluzin and colleagues could show that the detailed assessment of RV systolic and diastolic function provided complementary prognostic information in patients with HF.</s><s>In these studies, Meluzin and coworkers investigated a systolic and a diastolic parameter of RV function, the peak systolic tricuspid annular velocity, and peak early diastolic tricuspid annular velocity for prognosis of patients with HF.</s><s>The authors categorized patients into 4 groups with different constellations of the parameters demonstrated above and with different risk of cardiac events and death.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE 1</head><label>1</label><figDesc><div><p><s>Covariates associated with clinical endpoints</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>DD: E/e 0</cell><cell></cell><cell></cell><cell>HR</cell><cell>95% CI</cell><cell>P Value</cell></row><row><cell>All-cause death</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SD</cell><cell></cell><cell>≤15</cell><cell>&gt;15</cell><cell>SD</cell><cell>2.53</cell><cell>1.84-3.47</cell><cell>&lt;0.001</cell></row><row><cell>LVEF 35%-50%</cell><cell>Event</cell><cell>63 (15.9%)</cell><cell>38 (25.3%)</cell><cell>DD</cell><cell>1.75</cell><cell>1.17-2.61</cell><cell>0.004</cell></row><row><cell></cell><cell>N</cell><cell>99 (33.3%</cell><cell>150</cell><cell>SD*DD</cell><cell>0.63</cell><cell>0.38-1.05</cell><cell>0.073</cell></row><row><cell>LVEF &lt;35%</cell><cell>Event</cell><cell></cell><cell>67 (33.0%)</cell><cell>Age (per decade)</cell><cell>1.78</cell><cell>1.51-2.08</cell><cell>&lt;0.001</cell></row><row><cell></cell><cell>N</cell><cell>297</cell><cell>203</cell><cell>Female sex</cell><cell>0.75</cell><cell>0.57-1.01</cell><cell>0.055</cell></row><row><cell>Cardiac death</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SD</cell><cell></cell><cell>≤15</cell><cell>&gt;15</cell><cell>SD</cell><cell>3.51</cell><cell>2.19-5.64</cell><cell>&lt;0.001</cell></row><row><cell>LVEF 35%-50%</cell><cell>Event</cell><cell>25 (6.3%)</cell><cell>16 (10.7%)</cell><cell>DD</cell><cell>1.85</cell><cell>0.99-3.47</cell><cell>0.055</cell></row><row><cell></cell><cell>N</cell><cell>396</cell><cell>150</cell><cell>SD*DD</cell><cell>0.53</cell><cell>0.25-1.13</cell><cell>0.070</cell></row><row><cell>LVEF &lt;35%</cell><cell>Event</cell><cell>55 (18.5%)</cell><cell>33 (16.4%)</cell><cell>Age (per decade)</cell><cell>1.63</cell><cell>1.30-2.04</cell><cell>&lt;0.001</cell></row><row><cell></cell><cell>N</cell><cell>297</cell><cell>203</cell><cell>Female sex</cell><cell>0.88</cell><cell>0.59-1.31</cell><cell>0.523</cell></row><row><cell cols="2">Cardiac death and CV hospitalization</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>SD</cell><cell></cell><cell>≤15</cell><cell>&gt;15</cell><cell>SD</cell><cell></cell><cell></cell><cell>&lt;0.001</cell></row><row><cell>LVEF 35%-50%</cell><cell>Event</cell><cell>82 (20.8%)</cell><cell>40 (26.7%)</cell><cell>DD</cell><cell></cell><cell></cell><cell>0.341</cell></row><row><cell></cell><cell>N</cell><cell>396</cell><cell>150</cell><cell>SD*DD</cell><cell></cell><cell></cell><cell>0.709</cell></row><row><cell>LVEF &lt;35%</cell><cell>Event</cell><cell>112 (37.7%)</cell><cell>81 (40.3%)</cell><cell>Age (per decade)</cell><cell></cell><cell></cell><cell>0.263</cell></row><row><cell></cell><cell>N</cell><cell>297</cell><cell>203</cell><cell>Female sex</cell><cell></cell><cell></cell><cell>0.170</cell></row></table><note><p><s>Abbreviations: CI, confidence interval; CV, cardiovascular; DD, diastolic dysfunction; HR, hazard ratio; LVEF, left ventricular ejection fraction; SD, systolic dysfunction.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE 2</head><label>2</label><figDesc><div><p><s>Comparison of median hospital LOS</s></p></div></figDesc><table><row><cell></cell><cell>Nonsevere DD</cell><cell>Severe DD</cell><cell>P Value</cell></row><row><cell>All-cause hospitalization, d</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Nonsevere SD</cell><cell>10 (4-19)</cell><cell>9 (2-18)</cell><cell>0.741</cell></row><row><cell>Severe SD</cell><cell>14 (6-22)</cell><cell>25 (19-32)</cell><cell>0.677</cell></row><row><cell>P Value</cell><cell>0.020</cell><cell>0.035</cell><cell></cell></row><row><cell>CV hospitalization, d</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Nonsevere SD</cell><cell>10 (4-20)</cell><cell>7 (2-18)</cell><cell>0.374</cell></row><row><cell>Severe SD</cell><cell>13 (7-27)</cell><cell>15 (15-35)</cell><cell>0.487</cell></row><row><cell>P Value</cell><cell>0.072</cell><cell>0.021</cell><cell></cell></row></table><note><p><s>Abbreviations: CV, cardiovascular; DD, diastolic dysfunction; IQR, interquartile range; LOS, length of stay; SD, systolic dysfunction.</s></p></note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflicts of interest</head><p><s>The authors declare no potential conflicts of interest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SUPPORTING INFORMATION</head><p><s>Additional Supporting Information may be found online in the supporting information tab for this article.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Epidemiology of acute heart failure syndromes</title>
		<author>
			<persName><forename type="first">F</forename><surname>Alla</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zannad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filippatos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Heart Fail Rev</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="91" to="95" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Schocken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Benjamin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Fonarow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="2544" to="2565" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Trends in hospitalization for congestive heart failure</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Munir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Sharbaugh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Thoma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cardiol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="109" to="119" />
			<date type="published" when="1996">1996-2009. 2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Plasma brain natriuretic peptide to detect preclinical ventricular systolic or diastolic dysfunction: a community-based study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Redfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Rodeheffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Jacobsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="3176" to="3181" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Zile</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Brutsaert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="1387" to="1393" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lyass</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kraigher-Krainer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="24" to="30" />
			<date type="published" when="2011">2011. 2011</date>
		</imprint>
	</monogr>
	<note>Circulation</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Natriuretic peptides in the detection of preclinical diastolic or systolic dysfunction</title>
		<author>
			<persName><forename type="first">C</forename><surname>Luers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wachter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kleta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Res Cardiol</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="217" to="226" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Usefulness of a combination of systolic function by left ventricular ejection fraction and diastolic function by E/E 0 to predict prognosis in patients with heart failure</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hirata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Hyodo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hozumi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="1275" to="1279" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Trends in prevalence and outcome of heart failure with preserved ejection fraction</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Owan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">O</forename><surname>Hodge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Herges</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">355</biblScope>
			<biblScope unit="page" from="251" to="259" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Paulus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tschöpe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="263" to="271" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Paulus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tschöpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Sanderson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2539" to="2550" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Recommendations for the evaluation of left ventricular diastolic function by echocardiography</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Nagueh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Appleton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Gillebert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Echocardiogr</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="107" to="133" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">A network against failing hearts-introducing the German &quot;Competence Network Heart Failure</title>
		<author>
			<persName><forename type="first">F</forename><surname>Mehrhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Löffler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gelbrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="135" to="138" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Competence Network Heart Failure Germany. Reverse epidemiology in different stages of heart failure</title>
		<author>
			<persName><forename type="first">G</forename><surname>Guder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gelbrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Edelmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">184</biblScope>
			<biblScope unit="page" from="216" to="224" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The Biomaterialbank of the German Competence Network of Heart Failure (CNHF) is a valuable resource for biomedical and genetic research</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Posch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gelbrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pieske</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="108" to="111" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Cheitlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Aurigemma</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="1146" to="1162" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">American College of Cardiology/American Heart Association clinical competence statement echocardiography: a report of the American College of Cardiology/ American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Quinones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Douglas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Foster</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="1068" to="1089" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">F</forename><surname>Nagueh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Smiseth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Appleton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Echocardiogr</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="277" to="314" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Three-sided hypothesis testing: simultaneous testing of superiority, equivalence and inferiority</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Goeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Solari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Stijnen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="2117" to="2125" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">rhDNase as an example of recurrent event analysis</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Therneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Hamilton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Stat Med</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="2029" to="2047" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Flynn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Pina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Whellan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">301</biblScope>
			<biblScope unit="page" from="1451" to="1459" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Usefulness of tissue Doppler imaging for assessing left ventricular filling pressure in patients with stable severe systolic heart failure</title>
		<author>
			<persName><forename type="first">B</forename><surname>Gellen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Canoui-Poitrine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Lesault</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="1619" to="1624" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Heart failure with preserved ejection fraction is characterized by dynamic impairment of active relaxation and contraction of the left ventricle on exercise and associated with myocardial energy deficiency</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Phan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Abozguia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Nallur</forename><surname>Shivu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="402" to="409" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Myocardial structure and function differ in systolic and diastolic heart failure</title>
		<author>
			<persName><forename type="first">L</forename><surname>Van Heerebeek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Borbely</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">W</forename><surname>Niessen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="1966" to="1973" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Abudiab</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Redfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Melenovsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Heart Fail</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="776" to="785" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">T</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wenzelburger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="36" to="46" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Myocardial contractile inefficiency and dyssynchrony in heart failure with preserved ejection fraction and narrow QRS complex</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Phan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Abozguia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Shivu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Echocardiogr</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="201" to="206" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Impaired systolic function by strain imaging in heart failure with preserved ejection fraction</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kraigher-Krainer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Shah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Gupta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="447" to="456" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Incremental prognostic value of assessing left ventricular myocardial mechanics in patients with chronic systolic heart failure</title>
		<author>
			<persName><forename type="first">H</forename><surname>Motoki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Borowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shrestha</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="2074" to="2081" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Echocardiographic evaluation of diastolic function can be used to guide clinical care</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Little</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Oh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="802" to="809" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Is echocardiographic evaluation of diastolic function useful in determining clinical care? Doppler echocardiography yields dubious estimates of left ventricular diastolic pressures</title>
		<author>
			<persName><forename type="first">C</forename><surname>Tschöpe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Paulus</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="810" to="820" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Good prognostic value of the intraoperative tissue Doppler-derived index E/e 0 after non-cardiac surgery</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Cabrera Schulmeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Arriaza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Minerva Anestesiol</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="page" from="1013" to="1018" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Influence of left ventricular dysfunction (diastolic versus systolic) on long-term prognosis in patients with versus without diabetes mellitus having elective peripheral arterial surgery</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Van Kuijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Flu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Valentijn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="860" to="864" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Reversible left ventricular diastolic dysfunction on Doppler tissue imaging predicts a more favorable prognosis in chronic heart failure</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Hung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Chang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circ J</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="1145" to="1150" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Impact of left ventricular remodeling on diagnostic and prognostic value of tissue Doppler indices in chronic systolic heart failure</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Shrestha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mullens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Card Fail</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="128" to="134" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Combined right ventricular systolic and diastolic dysfunction represents a strong determinant of poor prognosis in patients with symptomatic heart failure</title>
		<author>
			<persName><forename type="first">J</forename><surname>Meluzin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Spinarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hude</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="164" to="173" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Prognostic importance of various echocardiographic right ventricular functional parameters in patients with symptomatic heart failure</title>
		<author>
			<persName><forename type="first">J</forename><surname>Meluzin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Spinarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hude</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Echocardiogr</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="435" to="444" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ponikowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Voors</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Anker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2129" to="2200" />
			<date type="published" when="2016">2016. 2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
